Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9192554 | 0.84 | CYP3A4 (0.53) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 | |
| SCHEMBL2818214 | 0.84 | CYP3A4 (0.53) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 | |
| SCHEMBL8217861 | 0.82 | ALDH1A1 (0.52) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 | |
| SCHEMBL19123836 | 0.82 | CYP3A4 (0.52) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 | |
| SCHEMBL12242147 | 0.82 | CYP3A4 (0.52) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 | |
| SCHEMBL15786418 | 0.82 | CYP3A4 (0.52) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 | |
| SCHEMBL8345288 | 0.80 | CYP3A4 (0.56) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 | |
| SCHEMBL6683323 | 0.80 | CYP3A4 (0.50) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 | |
| SCHEMBL5892149 | 0.80 | CYP3A4 (0.55) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 | |
| SCHEMBL17780067 | 0.80 | CYP3A4 (0.52) | CYP3A4L3MBTL1ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111315714-B | Etherification process | 英国石油有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-20210363084-A1 | Etherification Process | BP P.L.C. (GB) | 2021-11-25 | — | — | US | disclosed |
| US-20210363084-A1 | Etherification Process | BP P.L.C. (GB) | 2021-11-25 | — | — | US | disclosed |
| EP-3697749-B1 | ETHERIFICATION PROCESS | BP PLC (GB) | 2021-09-15 | — | — | EP | disclosed |
| EP-3697749-B1 | ETHERIFICATION PROCESS | BP PLC (GB) | 2021-09-15 | — | — | EP | disclosed |
| EP-3697749-A1 | ETHERIFICATION PROCESS | BP P.L.C. (GB) | 2020-08-26 | — | — | EP | disclosed |
| CN-111315714-A | Etherification process | 英国石油有限公司 | 2020-06-19 | — | — | CN | disclosed |
| WO-2019077146-A1 | ETHERIFICATION PROCESS | BP P.L.C. (GB) | 2019-04-25 | — | — | WO | disclosed |
| WO-2019077146-A1 | ETHERIFICATION PROCESS | BP P.L.C. (GB) | 2019-04-25 | — | — | WO | disclosed |
| EP-0580308-B1 | Working fluid composition for refrigeration machine | KAO CORP (JP) | 2000-11-15 | — | — | EP | disclosed |
| US-5395544-A | Ester-containing working fluid composition for refrigerating machine | KAO CORPORATION (JP) | 1995-03-07 | — | — | US | disclosed |
| EP-0580308-A1 | Working fluid composition for refrigeration machine | KAO CORPORATION (JP) | 1994-01-26 | — | — | EP | disclosed |
| US-4075222-A | VETERINARY MEDICINE, BACTERICIDES, FUNGICIDES, ANTIPROTOZOAN | ELI LILLY AND COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-4001230-A | ANTIBACTERIAL, ANTIPROTAZOAL | ELI LILLY AND COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
| US-3980794-A | Method for promoting growth of poultry with 3-(5-nitro-2-imidazolyl)pyrazoles | ELI LILLY AND COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
| US-3947467-A | ANTIBACTERIAL, ANTIPROTOZOAL, ANTIFUNGAL | ELI LILLY AND COMPANY (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210363084-A1 | Etherification Process | DHCR24, CYP8B1, ECH1 | CYP3A4 168/4885L3MBTL1 1388/4885ALDH1A1 161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.